RXO Earnings & Financial Statements
RXO, Inc.
$28.69
+$0.09(+0.31%)
62
Overall
40
Value
83
Tech
65
Quality
Market Cap
$4.72B
Volume
4.10M
52W Range
$10.43 - $29.90
Target Price
$26.56
RXO earnings and financial statements: RXO, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
RXO Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $5.74B | $4.55B | $3.93B | $4.80B |
| Cost of revenue | $4.92B | $3.85B | $2.97B | $3.62B |
| Operating income | -$79.00M | -$56.00M | $39.00M | $123.00M |
| EBITDA | $4.65B | $3.46B | $162.00M | $3.83B |
| Net income | -$100.00M | -$290.00M | $4.00M | $92.00M |
| EPS (diluted) | $-0.59 | $-2.17 | $0.03 | $0.79 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total assets | $3.28B | $3.41B | $1.82B | $2.03B |
| Total liabilities | $1.73B | $1.79B | $1.23B | $1.44B |
| Shareholders’ equity | $1.54B | $1.61B | $594.00M | $587.00M |
| Cash and equivalents | $17.00M | $35.00M | $5.00M | $98.00M |
| Long-term debt | $578.00M | $566.00M | $502.00M | $565.00M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating cash flow | $51.00M | -$12.00M | $89.00M | $310.00M |
| Capital expenditure | -$57.00M | -$45.00M | -$64.00M | -$57.00M |
| Free cash flow | -$8.00M | -$57.00M | $25.00M | $253.00M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RXO | $28.69 | +0.3% | 4.10M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |